300401 Zhejiang Garden Biopharmaceutical
- 16.73
- -0.06-0.36%
Zhejiang Garden Biopharmaceutical News
Zhejiang Garden Biopharmaceutical: Announcement on the Conversion of Convertible Corporate Bonds into Shares in the Second Quarter of 2024.
Zhejiang Garden Biopharmaceutical: Zhejiang Garden Biopharmaceutical Co., Ltd.'s entrusted management report for the issuance of convertible corporate bonds to unspecified targets (2023).
Zhejiang Garden Biopharmaceutical: Announcement regarding subsidiary obtaining pharmaceutical registration certificate.
Zhejiang Garden Biopharmaceutical: Announcement on Independent Director obtaining Independent Director Training Certificate.
Zhejiang Garden Biopharmaceutical: Zhejiang Garden Biopharmaceutical Co., Ltd. has issued convertible corporate bonds to unspecified investors. The 2024 tracking rating report is available.
Zhejiang Garden Biopharmaceutical: Announcement on the results of the “Garden Convertible Bonds” resale
Zhejiang Garden Biopharmaceutical: An indicative announcement on the resumption of stock conversion for “Garden Convertible Bonds”
Zhejiang Garden Biopharmaceutical: Notice on the Change of Sponsor Representative for Continued Supervision
Zhejiang Garden Biopharmaceutical: Third indicative announcement on the resale of “Garden Convertible Bonds”
Zhejiang Garden Biopharmaceutical: Second indicative announcement on the resale of “Garden Convertible Bonds”
Zhejiang Garden Biopharmaceutical: Announcement on the downward revision of the “Garden Convertible Bonds” conversion price
Zhejiang Garden Biopharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Zhejiang Garden Biopharmaceutical: Legal Opinion of Huayuan Biotech's 2024 Second Extraordinary General Meeting of Shareholders
Zhejiang Garden Biopharmaceutical: Inspection opinions of Minsheng Securities Co., Ltd. on matters relating to the resale of convertible corporate bonds of Zhejiang Huayuan Biomedical Co., Ltd.
Zhejiang Garden Biopharmaceutical: An indicative announcement on the suspension of stock conversion for “Garden Convertible Bonds”
Zhejiang Garden Biopharmaceutical: Legal Opinion on the Resale of Convertible Corporate Bonds of Zhejiang Huayuan Biomedical Co., Ltd.
Zhejiang Garden Biopharmaceutical: First indicative announcement on the resale of “Garden Convertible Bonds”
Zhejiang Garden Biopharmaceutical: Zhejiang Garden Biopharmaceutical Co., Ltd. issued a report on temporary trusteeship management of convertible corporate bonds to unspecified targets
Zhejiang Garden Biopharmaceutical: Announcement on the adjustment of the conversion price of convertible corporate bonds
Zhejiang Garden Biopharmaceutical: Legal Opinion of “Garden Convertible Bonds” 2024 First Bondholders' Meeting
Analysis
Price Target
No Data
